Growth Metrics

Biofrontera (BFRI) Return on Equity: 2021-2024

Historic Return on Equity for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to -3.85%.

  • Biofrontera's Return on Equity rose 641.00% to 4.85% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.85%, marking a year-over-year increase of 641.00%. This contributed to the annual value of -3.85% for FY2024, which is 245.00% down from last year.
  • As of FY2024, Biofrontera's Return on Equity stood at -3.85%, which was down 174.15% from -1.40% recorded in FY2023.
  • Biofrontera's 5-year Return on Equity high stood at -0.04% for FY2022, and its period low was -4.39% during FY2021.
  • In the last 3 years, Biofrontera's Return on Equity had a median value of -1.40% in 2023 and averaged -1.76%.
  • Its Return on Equity has fluctuated over the past 5 years, first surged by 436bps in 2022, then slumped by 245bps in 2024.
  • Over the past 4 years, Biofrontera's Return on Equity (Yearly) stood at -4.39% in 2021, then skyrocketed by 436bps to -0.04% in 2022, then plummeted by 137bps to -1.40% in 2023, then crashed by 245bps to -3.85% in 2024.